PRESS RELEASE published on 10/09/2023 at 22:50, 1 year 1 month ago IGEA Pharma N.V.: IGEA to update on RBCARE business combination
PRESS RELEASE published on 10/03/2023 at 23:55, 1 year 1 month ago IGEA Pharma N.V.: IGEA and RBCARE2023 signed to combine their businesses
PRESS RELEASE published on 09/30/2023 at 19:15, 1 year 1 month ago IGEA Pharma N.V.: IGEA discloses its half-year figures 2023
PRESS RELEASE published on 09/28/2023 at 19:15, 1 year 1 month ago IGEA Pharma N.V.: Convening notice and Agenda “Annual Shareholder Meeting” IGEA Pharma N.V.
PRESS RELEASE published on 08/30/2023 at 22:30, 1 year 2 months ago IGEA Pharma N.V.: IGEA filed the appeal on SIX decision of delisting
PRESS RELEASE published on 08/04/2023 at 22:30, 1 year 3 months ago IGEA Pharma N.V.: IGEA to update on SIX decision
PRESS RELEASE published on 07/31/2023 at 00:35, 1 year 3 months ago IGEA Pharma N.V.: IGEA discloses its Annual Report 2022
PRESS RELEASE published on 05/31/2023 at 22:35, 1 year 5 months ago IGEA Pharma N.V.: IGEA to apply for a further extension of its disclosure obligations
PRESS RELEASE published on 05/30/2023 at 01:00, 1 year 5 months ago IGEA Pharma N.V.: IGEA to update on strategic refocusing decisions.
PRESS RELEASE published on 05/15/2023 at 22:50, 1 year 6 months ago IGEA Pharma N.V.: IGEA to update on unaudited key figures and ongoing matters
Published on 11/21/2024 at 13:30, 36 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 36 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 31 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 51 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 8 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 46 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
